
Encompass Health (EHC) Stock Forecast & Price Target
Encompass Health (EHC) Analyst Ratings
Bulls say
Encompass Health is well-positioned for future growth with a strong balance sheet and expansion opportunities. Despite potential challenges, the company's current focus on EBITDA growth and use of AI sets it apart from competitors. The recent OIG report may have minimal impact on investors, and the company's CEO is addressing potential capacity constraints. However, it will be important to monitor industry regulatory changes and the impact of RCD in 2026 on the company's business model. Overall, Encompass Health has a solid foundation and potential for continued success in the post-acute healthcare services sector.
Bears say
Encompass Health is likely to experience future growth due to their strong market position and potential for expansion. However, the company's sole reliance on the inpatient rehabilitation segment makes it vulnerable to any regulatory or reimbursement changes. Additionally, its valuation based on multiples may indicate a potential overvaluation. Therefore, there is a negative outlook on EHC's stock due to potential risks and overvaluation.
This aggregate rating is based on analysts' research of Encompass Health and is not a guaranteed prediction by Public.com or investment advice.
Encompass Health (EHC) Analyst Forecast & Price Prediction
Start investing in Encompass Health (EHC)
Order type
Buy in
Order amount
Est. shares
0 shares